Fate Therapeutics Inc SEC filings FATE

Fate Therapeutics Inc has 855 filings in SEC EDGAR's recent list, going back to May 2, 2008. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (material agreement, agreement ended). The company's fiscal year ends on December 31.

Fate Therapeutics Inc SEC filings
Form Description Filed Period
S-3 Shelf registration Nov 5, 2026 —
424B5 Prospectus supplement Nov 5, 2026 —
8-K Current report
Material agreement, Agreement ended
Nov 5, 2026 Nov 5, 2026
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Other events
Sep 28, 2026 Sep 25, 2026
S-8 Employee stock plan registration Aug 13, 2026 —
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 15, 2026 Jun 12, 2026
8-K Current report
Other events
Jun 4, 2026 Jun 4, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
ARS Annual report to shareholders Apr 24, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Jun 12, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 27, 2025 Oct 26, 2025
S-8 Employee stock plan registration Oct 20, 2025 —
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 14, 2025 Oct 10, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations, Exit or restructuring costs
Aug 12, 2025 Aug 7, 2025
8-K/A Amended current report
Shareholder vote results
Jun 17, 2025 May 29, 2025
S-8 Employee stock plan registration Jun 4, 2025 —
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
May 30, 2025 May 29, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
ARS Annual report to shareholders Apr 17, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 17, 2025 —
DEF 14A Proxy statement Apr 17, 2025 May 29, 2025
PRE 14A Preliminary proxy statement Apr 7, 2025 May 29, 2025
10-K Annual report Mar 5, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 5, 2025 Mar 5, 2025
8-K Current report
Officer or director change
Jan 6, 2025 Dec 31, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 29, 2024 Nov 27, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Material agreement, Officer or director change
Aug 30, 2024 Aug 26, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 31, 2024 Jul 29, 2024
S-8 Employee stock plan registration Jun 10, 2024 —
8-K Current report
Bylaw or fiscal year change
Jun 10, 2024 Jun 7, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 7, 2024 Jun 3, 2024
8-K Current report
Officer or director change
May 31, 2024 May 30, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
8-K Current report
Regulation FD disclosure, Other events
May 9, 2024 May 9, 2024
424B3 Prospectus May 2, 2024 —
EFFECT Filing Apr 29, 2024 —
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 7, 2024
CORRESP Letter to the SEC Apr 25, 2024 —
UPLOAD Letter from the SEC Apr 24, 2024 —
S-3 Shelf registration Apr 18, 2024 —
PRE 14A Preliminary proxy statement Apr 16, 2024 Jun 7, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Mar 21, 2024 Mar 19, 2024
424B5 Prospectus supplement Mar 20, 2024 —
10-K Annual report Feb 26, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 26, 2024 Feb 26, 2024
EFFECT Filing Nov 27, 2023 —
CORRESP Letter to the SEC Nov 21, 2023 —
UPLOAD Letter from the SEC Nov 15, 2023 —
8-K Current report
Material agreement, Agreement ended
Nov 8, 2023 Nov 8, 2023
S-3 Shelf registration Nov 8, 2023 —
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
8-K Current report
Other events
Sep 1, 2023 Aug 30, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Shareholder vote results
Jun 9, 2023 Jun 6, 2023
8-K Current report
Officer or director change
Jun 8, 2023 Jun 8, 2023
8-K Current report
Other events
Jun 7, 2023 Jun 7, 2023
10-Q Quarterly report May 3, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 3, 2023 May 3, 2023
ARS Annual report to shareholders Apr 21, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 21, 2023 —
DEF 14A Proxy statement Apr 21, 2023 —
8-K Current report
Listing notice, Bylaw or fiscal year change
Apr 19, 2023 Apr 13, 2023
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
8-K Current report
Agreement ended, Exit or restructuring costs, Officer or director change, Other events
Jan 5, 2023 Jan 3, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Nov 7, 2022 Nov 7, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
10-Q Quarterly report Aug 3, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 3, 2022 Aug 3, 2022
8-K Current report
Material agreement, Regulation FD disclosure
Jun 30, 2022 Jun 28, 2022
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2022 Jun 9, 2022
S-8 Employee stock plan registration Jun 9, 2022 —
10-Q Quarterly report May 4, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 4, 2022 May 4, 2022
DEFA14A Additional proxy material Apr 25, 2022 —
DEF 14A Proxy statement Apr 25, 2022 Jun 9, 2022
S-8 Employee stock plan registration Feb 28, 2022 —
10-K Annual report Feb 28, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 28, 2022 Feb 28, 2022
8-K Current report
Other events
Dec 14, 2021 Dec 13, 2021
8-K Current report
Material agreement, Agreement ended
Nov 4, 2021 Nov 4, 2021
S-3ASR Automatic shelf registration Nov 4, 2021 —
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
10-Q Quarterly report Aug 4, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 4, 2021 Aug 4, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 4, 2021 Aug 3, 2021
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 7, 2021 Jun 2, 2021
10-Q Quarterly report May 5, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 5, 2021 May 5, 2021
DEFA14A Additional proxy material Apr 21, 2021 —
DEF 14A Proxy statement Apr 21, 2021 Jun 2, 2021
PRE 14A Preliminary proxy statement Apr 7, 2021 Jun 2, 2021
8-K Current report
Officer or director change
Mar 25, 2021 Mar 19, 2021
S-8 Employee stock plan registration Feb 24, 2021 —
10-K Annual report Feb 24, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 24, 2021 Feb 24, 2021
8-K Current report
Material agreement, Other events
Jan 8, 2021 Jan 4, 2021
424B5 Prospectus supplement Jan 7, 2021 —
FWP Free writing prospectus Jan 5, 2021 —
424B5 Prospectus supplement Jan 4, 2021 —
8-K Current report
Bylaw or fiscal year change
Dec 22, 2020 Dec 17, 2020
8-K Current report
Other events
Dec 7, 2020 Dec 4, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Aug 19, 2020 Aug 17, 2020
10-Q Quarterly report Aug 5, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 5, 2020 Aug 5, 2020
D Filing Jul 6, 2020 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jun 10, 2020 Jun 8, 2020
424B5 Prospectus supplement Jun 10, 2020 —
424B5 Prospectus supplement Jun 8, 2020 —
10-Q Quarterly report May 11, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 11, 2020 May 11, 2020
8-K Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
May 5, 2020 May 1, 2020
8-K Current report
Other events
Apr 28, 2020 Apr 17, 2020
D Filing Apr 21, 2020 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Apr 2, 2020 Apr 2, 2020
DEFA14A Additional proxy material Mar 20, 2020 —
DEF 14A Proxy statement Mar 20, 2020 May 1, 2020
S-8 Employee stock plan registration Mar 2, 2020 —
10-K Annual report Mar 2, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 2, 2020 Mar 2, 2020
8-K Current report
Material agreement, New debt
Jan 10, 2020 Jan 7, 2020
8-K Current report
Agreement ended
Nov 14, 2019 Nov 13, 2019
10-Q Quarterly report Nov 5, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 5, 2019 Nov 5, 2019
8-K Current report
Material agreement, Other events
Sep 13, 2019 Sep 11, 2019
424B5 Prospectus supplement Sep 13, 2019 —
424B5 Prospectus supplement Sep 11, 2019 —
8-K/A Amended current report
Results of operations
Aug 7, 2019 Aug 6, 2019
10-Q Quarterly report Aug 6, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 6, 2019 Aug 6, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 17, 2019 Jul 15, 2019
10-Q Quarterly report May 7, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 7, 2019 May 7, 2019
8-K Current report
Shareholder vote results
May 7, 2019 May 3, 2019
DEFA14A Additional proxy material Apr 8, 2019 —
DEF 14A Proxy statement Mar 22, 2019 May 3, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 18, 2019 Mar 14, 2019
S-8 Employee stock plan registration Mar 8, 2019 —
10-K Annual report Mar 5, 2019 Dec 31, 2018
8-K Current report
Results of operations
Mar 5, 2019 Mar 5, 2019
CT ORDER Filing Feb 27, 2019 —
10-Q/A Amended quarterly report Feb 8, 2019 Sep 30, 2018
8-K Current report
Other events
Jan 4, 2019 Jan 4, 2019
8-K Current report
Material agreement
Nov 21, 2018 Nov 21, 2018
S-3ASR Automatic shelf registration Nov 21, 2018 —
8-K Current report
Officer or director change
Nov 7, 2018 Nov 5, 2018
10-Q Quarterly report Nov 1, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 1, 2018 Nov 1, 2018
8-K Current report
Material agreement, Other events
Sep 21, 2018 Sep 20, 2018
424B5 Prospectus supplement Sep 21, 2018 —
424B5 Prospectus supplement Sep 20, 2018 —
8-K Current report
Material agreement, Regulation FD disclosure
Sep 18, 2018 Sep 14, 2018
8-K Current report
Material agreement, Regulation FD disclosure
Sep 13, 2018 Sep 11, 2018
CT ORDER Filing Sep 12, 2018 —
10-Q Quarterly report Aug 6, 2018 Jun 30, 2018
8-K Current report
Results of operations
Aug 6, 2018 Aug 6, 2018
8-K Current report
Officer or director change, Other events
Aug 1, 2018 Jul 31, 2018
CT ORDER Filing Jul 19, 2018 —
8-K Current report
Material agreement, Officer or director change
Jun 1, 2018 May 25, 2018
8-K Current report
Material agreement, Regulation FD disclosure
May 18, 2018 May 15, 2018
EFFECT Filing May 14, 2018 —
CORRESP Letter to the SEC May 11, 2018 —
UPLOAD Letter from the SEC May 11, 2018 —
10-Q Quarterly report May 10, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 10, 2018 May 10, 2018
8-K Current report
Shareholder vote results, Other events
May 4, 2018 May 2, 2018
S-3 Shelf registration May 4, 2018 —
CT ORDER Filing Mar 19, 2018 —
DEFA14A Additional proxy material Mar 16, 2018 —
DEF 14A Proxy statement Mar 16, 2018 May 2, 2018
S-8 Employee stock plan registration Mar 8, 2018 —
10-K Annual report Mar 5, 2018 Dec 31, 2017
8-K Current report
Results of operations
Mar 5, 2018 Mar 5, 2018
8-K Current report
Officer or director change
Jan 17, 2018 Jan 14, 2018
8-K Current report
Material agreement, Other events
Dec 14, 2017 Dec 12, 2017

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
FATE (Nasdaq)
Fiscal year ends
December 31
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1434316

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.